Cargando…

Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue

The growth hormone (GH) and insulin-like growth factor I (IGF-I) axis were studied in streptozotocin (STZ) diabetic and nondiabetic female mice following intravenous (IV) injection of the GH secretagogue (GHS) ipamorelin or saline. On day 14, blood samples were obtained before and 10 minutes after t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johansen, Peter B., Segev, Yael, Landau, Daniel, Phillip, Moshe, Flyvbjerg, Allan
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478601/ https://www.ncbi.nlm.nih.gov/pubmed/14630569 http://dx.doi.org/10.1155/EDR.2003.73

Ejemplares similares

Growth hormone (GH)–releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?
por: Hersch, Elizabeth C, et al.
Publicado: (2008)

LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency
por: Bright, George, et al.
Publicado: (2021)

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

New insights of growth hormone (GH) actions from tissue-specific GH receptor knockouts in mice
por: List, Edward O., et al.
Publicado: (2019)

GH deficiency status combined with GH receptor polymorphism affects response to GH in children
por: Valsesia, Armand, et al.
Publicado: (2015)

Development of a Predictive Enrichment Marker for the Oral GH Secretagogue LUM-201 in Pediatric Growth Hormone Deficiency
por: Bright, George M, et al.
Publicado: (2021)

Growth Hormone (GH) and Cardiovascular System
por: Caicedo, Diego, et al.
Publicado: (2018)

Changes in the Growth Hormone-IGF-I Axis in Non-obese Diabetic Mice
por: Landau, Daniel, et al.
Publicado: (2000)

Regulation of GH and GH Signaling by Nutrients
por: Caputo, Marina, et al.
Publicado: (2021)

Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients
por: Morrhaye, Gabriel, et al.
Publicado: (2009)

No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH Treatment
por: Tanaka, Toshiaki, et al.
Publicado: (2006)

Is GH Replacement for Adult GH Deficiency Safe?
por: Melmed, Shlomo
Publicado: (2022)

Diagnosis of growth hormone (GH) deficiency: comparison of pituitary stalk interruption syndrome and transient GH deficiency
por: Louvel, Murielle, et al.
Publicado: (2009)

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency
por: Kohno, Hitoshi, et al.
Publicado: (2012)

Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome
por: Donze, Stephany H., et al.
Publicado: (2019)

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height
por: Prodam, Flavia, et al.
Publicado: (2014)

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome
por: Giménez-Palop, Olga, et al.
Publicado: (2021)

Immobilization of Glycoside Hydrolase Families GH1, GH13, and GH70: State of the Art and Perspectives
por: Graebin, Natália G., et al.
Publicado: (2016)

GH Responsiveness to Combined GH-Releasing Hormone and Arginine Administration in Obese Patients with Fibromyalgia Syndrome
por: Rigamonti, Antonello E., et al.
Publicado: (2017)

Genetic determinants of growth hormone and GH-related phenotypes
por: Hallengren, Erik, et al.
Publicado: (2017)

Neuroregulation of the Hypothalamus-Pituitary-Adrenal (HPA) Axis in Humans: Effects of GABA-, Mineralocorticoid-, and GH-Secretagogue-Receptor Modulation
por: Giordano, Roberta, et al.
Publicado: (2006)

Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications
por: Smyczynska, Joanna, et al.
Publicado: (2010)

GH and Senescence: A New Understanding of Adult GH Action
por: Chesnokova, Vera, et al.
Publicado: (2021)

Functional analysis of GhCHS, GhANR and GhLAR in colored fiber formation of Gossypium hirsutum L
por: Gao, Jianfang, et al.
Publicado: (2019)

A long-acting GH receptor antagonist through fusion to GH binding protein
por: Wilkinson, Ian R., et al.
Publicado: (2016)

Functional changes of the liver in the absence of growth hormone (GH) action – Proteomic and metabolomic insights from a GH receptor deficient pig model
por: Riedel, Evamaria O., et al.
Publicado: (2020)

Isolation and Characterization of the Arapaima gigas Growth Hormone (ag-GH) cDNA and Three-Dimensional Modeling of This Hormone in Comparison with the Human Hormone (hGH)
por: Lima, Eliana Rosa, et al.
Publicado: (2023)

Correction to: Functional analysis of GhCHS, GhANR and GhLAR in colored fiber formation of Gossypium hirsutum L
por: Gao, Jianfang, et al.
Publicado: (2020)

Characterization of Neurospora crassa GH16, GH17, and GH72 gene families of cell wall crosslinking enzymes
por: Patel, Pavan, et al.
Publicado: (2022)

Atypical Course of a Patient With AIP-Positive Acromegaly: From GH Excess to GH Deficiency and Back to GH Excess
por: García-de-la-Torre, Keren-Sandyn, et al.
Publicado: (2023)

Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
por: Höybye, Charlotte, et al.
Publicado: (2014)

Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study
por: Soliman, Ashraf T, et al.
Publicado: (2019)

Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2014)

MON-459 ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, Attenuates GH Hypersecretion in Human GH-Secreting, Pituitary Adenoma-Derived Cells
por: Zhou, Cuiqi, et al.
Publicado: (2019)

Boosting of enzymatic softwood saccharification by fungal GH5 and GH26 endomannanases
por: von Freiesleben, Pernille, et al.
Publicado: (2018)

Unraveling the subtleties of β-(1→3)-glucan phosphorylase specificity in the GH94, GH149, and GH161 glycoside hydrolase families
por: Kuhaudomlarp, Sakonwan, et al.
Publicado: (2019)

The GhMAP3K62-GhMKK16-GhMPK32 kinase cascade regulates drought tolerance by activating GhEDT1-mediated ABA accumulation in cotton
por: Chen, Lin, et al.
Publicado: (2022)

Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa
por: Maiza, Jean Christophe, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_j9inhqi4teapmvs40odcnot2er